GLP-1 medications, such as Ozempic and Zepbound, offer new hope by helping people lose weight and improve their overall health
When to Avoid an Injection Site Avoid the site and pick another approved area if the skin is bruised, tender, hard or lumpy
However, large Phase 3 combination trials provide extensive safety and effectiveness information
The mechanism centers on inflammation modulation rather than direct receptor agonism
Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge On July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will roll out a new, temporary program covering GLP-1s for obesity for people with Medicare
Tirzepatide (Mounjaro) was approved by the FDA in May 2022 for use in combination with diet and exercise to improve blood sugar control in adults with type 2 diabetes